PT  - JOURNAL ARTICLE
AU  - Bharathnag Nagappa
AU  - Manikandanesan Sakthivel
AU  - Yamini Marimuthu
AU  - Aayushi Rastogi
AU  - Archana Ramalingam
AU  - Shiv Kumar Sarin
TI  - Now casting and Forecasting of COVID-19 outbreak in the National Capital Region of Delhi
AID  - 10.1101/2020.05.01.20087783
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.01.20087783
4099  - http://medrxiv.org/content/early/2020/05/10/2020.05.01.20087783.short
4100  - http://medrxiv.org/content/early/2020/05/10/2020.05.01.20087783.full
AB  - Objectives The study aimed to estimate the disease burden due to COVID-19 in the scenarios of unchecked spread and with various public health interventions in New Delhi.Methods We adopted Susceptible, Exposed, Infected and Recovered (SEIR) model to estimate the course of COVID-19 outbreak in Delhi population and effect of public health intervention on the pandemic. We first estimated the basic reproductive rate (R0) based on the evidence from Wuhan, then ran the model considering no intervention implemented, followed by case isolation, social distancing, and lockdown, each implemented in isolation and in combinations to estimate the number of cases. Markov’s model was used to estimate the number of cases in various clinical scenarios of the disease. Sensitivity analysis conducted to estimate the effect of asymptomatic cases on case based interventions.Results Estimated R0 in Delhi population was 6.18 (range 4.15 – 12.2). Effective reproductive rate (Rt) was least for case isolation (3.5). Lockdown showed highest reduction (28%) in number of prevalent cases on peak day and 22% reduction in patients in need of intensive care unit (ICU). Case isolation and lockdown together resulted in 50% reduction in number of prevalent cases and 42% reduction in patients in need of ICU care. Sensitivity analysis showed that the effect of case isolation was inversely proportionate to the proportion of asymptomatic (hidden) cases.Conclusions Interventions should be implemented in combinations of individual and community level interventions to gain better outcome. Identifying and isolation of all cases as early as possible is important to flatten the pandemic curve.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot ApplicableFunding StatementNilAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made accessible if required.